BACKGROUND: Psychological stressors might contribute to the severity of chronic inflammatory diseases such as psoriasis by dysregulating hypothalamic-pituitary-adrenal (HPA) axis activity. OBJECTIVES: To evaluate the role of cortisol, a key component of the HPA axis, in reaction to psychological stress in patients with psoriasis. METHODS: Serum cortisol, clinical indicators of disease severity (Psoriasis Area and Severity Index) and self-report measures of daily stressors were measured monthly for 6 months in 62 patients with psoriasis. RESULTS: In addition to the previous findings in this sample showing that peak levels of daily stressors predicted an increase in disease severity a month later, the peak levels of daily stressors were also significantly associated with a lower cortisol level. Moreover, patients who persistently experienced higher levels of daily stressors had lower mean cortisol levels than patients who experienced lower levels of daily stressors. CONCLUSIONS: Results suggest that daily stressors influence disease outcome in patients with psoriasis by affecting cortisol levels at moments of high stress. Furthermore, patients with persistently high levels of stressors seem to have a specific psychophysiological profile of lowered cortisol levels and may be particularly vulnerable to the influence of stressors on their psoriasis.
BACKGROUND: Psychological stressors might contribute to the severity of chronic inflammatory diseases such as psoriasis by dysregulating hypothalamic-pituitary-adrenal (HPA) axis activity. OBJECTIVES: To evaluate the role of cortisol, a key component of the HPA axis, in reaction to psychological stress in patients with psoriasis. METHODS: Serum cortisol, clinical indicators of disease severity (Psoriasis Area and Severity Index) and self-report measures of daily stressors were measured monthly for 6 months in 62 patients with psoriasis. RESULTS: In addition to the previous findings in this sample showing that peak levels of daily stressors predicted an increase in disease severity a month later, the peak levels of daily stressors were also significantly associated with a lower cortisol level. Moreover, patients who persistently experienced higher levels of daily stressors had lower mean cortisol levels than patients who experienced lower levels of daily stressors. CONCLUSIONS: Results suggest that daily stressors influence disease outcome in patients with psoriasis by affecting cortisol levels at moments of high stress. Furthermore, patients with persistently high levels of stressors seem to have a specific psychophysiological profile of lowered cortisol levels and may be particularly vulnerable to the influence of stressors on their psoriasis.
Authors: Bárbara Isabel Roque Cunha Ferreira; José Luís Pio Da Costa Abreu; José Pedro Gaspar Dos Reis; Américo Manuel Da Costa Figueiredo Journal: J Clin Aesthet Dermatol Date: 2016-06-01
Authors: Sundus S Lateef; Mina Al Najafi; Amit K Dey; Mariyam Batool; Khaled M Abdelrahman; Domingo E Uceda; Aarthi S Reddy; Maryia D Svirydava; Navya Nanda; Jenis E Ortiz; Nina Prakash; Justin A Rodante; Andrew Keel; Wunan Zhou; Marcus Y Chen; Martin P Playford; Heather L Teague; Ahmed A Tawakol; Joel M Gelfand; Tiffany M Powell-Wiley; Nehal N Mehta Journal: Atherosclerosis Date: 2020-07-29 Impact factor: 5.162
Authors: Eddy Wang; Katy Chong; Mei Yu; Noushin Akhoundsadegh; David J Granville; Jerry Shapiro; Kevin J McElwee Journal: PLoS One Date: 2013-04-26 Impact factor: 3.240
Authors: Sabine J M de Brouwer; Floris W Kraaimaat; Fred C G J Sweep; Rogier T Donders; Agnes Eijsbouts; Saskia van Koulil; Piet L C M van Riel; Andrea W M Evers Journal: PLoS One Date: 2011-12-06 Impact factor: 3.240
Authors: Danielle J P Bartels; Antoinette I M van Laarhoven; Elise A Haverkamp; Oliver H Wilder-Smith; A Rogier T Donders; Henriët van Middendorp; Peter C M van de Kerkhof; Andrea W M Evers Journal: PLoS One Date: 2014-03-19 Impact factor: 3.240